Iovance Biotherapeutics Inc’s recent filing unveils that its Director Maynard Ryan D unloaded Company’s shares for reported $0.5 million on Nov 12 ’24. In the deal valued at $10.06 per share,50,000 shares were sold. As a result of this transaction, Maynard Ryan D now holds 7,500 shares worth roughly $69900.0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Maynard Ryan D bought 50,000 shares, generating $503,104 in total proceeds.
Before that, MCPEAK MERRILL A bought 250,000 shares. Iovance Biotherapeutics Inc shares valued at $2,287,500 were divested by the Director at a price of $9.15 per share. As a result of the transaction, MCPEAK MERRILL A now holds 320,150 shares, worth roughly $2.98 million.
UBS initiated its Iovance Biotherapeutics Inc [IOVA] rating to a Buy in a research note published on October 24, 2024; the price target was $17. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who decreased its forecast for the stock in late July from “an Overweight” to “a Neutral”. Goldman began covering IOVA with “Buy” recommendation on November 20, 2023. Barclays maintained its rating on September 18, 2023. It rated IOVA as “an Overweight”.
Price Performance Review of IOVA
On Friday, Iovance Biotherapeutics Inc [NASDAQ:IOVA] saw its stock fall -0.85% to $9.32. Over the last five days, the stock has gained 13.11%. Iovance Biotherapeutics Inc shares have risen nearly 14.64% since the year began. Nevertheless, the stocks have risen 64.08% over the past one year. While a 52-week high of $18.33 was reached on 02/28/24, a 52-week low of $5.41 was recorded on 08/05/24. SMA at 50 days reached $9.84, while 200 days put it at $10.78.
Levels Of Support And Resistance For IOVA Stock
The 24-hour chart illustrates a support level at 9.17, which if violated will result in even more drops to 9.02. On the upside, there is a resistance level at 9.49. A further resistance level may holdings at 9.67. The Relative Strength Index (RSI) on the 14-day chart is 47.71, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.37, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 53.47%. Stochastics %K at 48.38% indicates the stock is a holding.
How much short interest is there in Iovance Biotherapeutics Inc?
A steep rise in short interest was recorded in Iovance Biotherapeutics Inc stocks on 2024-11-15, dropping by -6.35 million shares to a total of 53.99 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 60.34 million shares. There was a decline of -11.76%, which implies that there is a negative sentiment for the stock.
